ORTHOPEDIATRICS CORP Stockholders Equity

Quick Answer

ORTHOPEDIATRICS CORP reported Stockholders Equity of $346.60 million for fiscal year 2025.

ORTHOPEDIATRICS CORP Stockholders Equity — Annual History

Fiscal Year Stockholders Equity YoY Change
2025 $346.60M -2.2%
2024 $354.57M -6.0%
2023 $377.02M -0.4%
2022 $378.65M +68.0%
2021 $225.37M -4.0%
2020 $234.77M +64.9%
2019 $142.36M +74.2%
2018 $81.73M +72.1%
2017 $47.49M +172.7%
2016 -$65.31M -20.7%
2015 -$54.11M -26.9%
2014 -$42.65M

Quarterly Stockholders Equity

Quarter Ending Stockholders Equity YoY QoQ
September 30, 2025 $349.31M -5.8% -1.7%
June 30, 2025 $355.51M -4.2% +2.4%
March 31, 2025 $347.15M -6.3% -2.1%
December 31, 2024 $354.57M -6.0% -4.4%
September 30, 2024 $370.92M -0.9% -0.1%
June 30, 2024 $371.29M -2.4% +0.2%
March 31, 2024 $370.58M -0.7% -1.7%
December 31, 2023 $377.02M -0.4% +0.7%
  • ORTHOPEDIATRICS CORP showed a decrease of -2.2% in Stockholders Equity compared to the prior fiscal year.
  • Over the 2014–2025 period, ORTHOPEDIATRICS CORP’s stockholders equity has grown by 912.6% (from -$42.65 million to $346.60 million).
  • The most recent figure is from ORTHOPEDIATRICS CORP’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 4, 2026.
  • All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.

Last verified:

Leave a Comment